03/14/2024 3:31 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:04 PM | Regeneron Pharmaceuticals (Issuer) STAHL NEIL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:04 PM | Regeneron Pharmaceuticals (Issuer) SING GEORGE L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:04 PM | LAROSA JOSEPH J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 3:34 PM | LAROSA JOSEPH J (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 2:25 PM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:15 PM | Regeneron Pharmaceuticals (Issuer) Van Plew Daniel P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/13/2024 4:12 PM | Regeneron Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024 5:19 PM | Capital World Investors (Filed by) Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 11:22 AM | Fenimore Christopher R. (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024 4:59 PM | Landry Robert E (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 4:07 PM | LAROSA JOSEPH J (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 4:06 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 3:05 PM | Regeneron Pharmaceuticals (Issuer) RYAN ARTHUR F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 8:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/02/2024 6:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 3:47 PM | Regeneron Pharmaceuticals (Subject) RYAN ARTHUR F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 3:52 PM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 4:02 PM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024 10:10 AM | JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by) Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 10:11 AM | JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by) Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024 3:17 PM | GOLDSTEIN JOSEPH L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 5:30 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:19 PM | Landry Robert E (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:19 PM | LAROSA JOSEPH J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:20 PM | Regeneron Pharmaceuticals (Issuer) YANCOPOULOS GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:22 PM | Fenimore Christopher R. (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:15 PM | Regeneron Pharmaceuticals (Issuer) Thompson Craig B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:16 PM | Guarini Kathryn (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:17 PM | Regeneron Pharmaceuticals (Issuer) Schenkein David P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:17 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:06 PM | BROWN MICHAEL S (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | GOLDSTEIN JOSEPH L (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Regeneron Pharmaceuticals (Issuer) SING GEORGE L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:08 PM | Regeneron Pharmaceuticals (Issuer) RYAN ARTHUR F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:10 PM | POON CHRISTINE A (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 10:31 AM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:28 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:11 PM | Regeneron Pharmaceuticals (Subject) YANCOPOULOS GEORGE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 3:22 PM | BROWN MICHAEL S (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
12/26/2023 3:08 PM | Fenimore Christopher R. (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 3:22 PM | Fenimore Christopher R. (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:10 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:11 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 10:41 AM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:02 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:02 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 3:02 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023 3:45 PM | Regeneron Pharmaceuticals (Subject) RYAN ARTHUR F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 6:10 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 6:22 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 3:48 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023 3:06 PM | Regeneron Pharmaceuticals (Issuer) Zoghbi Huda Y (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 3:02 PM | Regeneron Pharmaceuticals (Subject) Zoghbi Huda Y (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023 2:49 PM | Regeneron Pharmaceuticals (Subject) Tessier-Lavigne Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 3:05 PM | Decibel Therapeutics, Inc. (Subject) Regeneron Pharmaceuticals (Filed by)
| Form SC 13D/A | |
09/25/2023 7:48 AM | Decibel Therapeutics, Inc. (Subject) Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
09/12/2023 3:38 PM | Decibel Therapeutics, Inc. (Subject) Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
09/12/2023 3:01 PM | Regeneron Pharmaceuticals (Issuer) Schenkein David P (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/12/2023 3:03 PM | Guarini Kathryn (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:04 PM | Regeneron Pharmaceuticals (Issuer) Schenkein David P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 3:14 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023 6:46 AM | Decibel Therapeutics, Inc. (Subject) Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T | |
08/24/2023 3:27 PM | Regeneron Pharmaceuticals (Subject) Van Plew Daniel P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023 4:06 PM | Landry Robert E (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023 3:52 PM | POON CHRISTINE A (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023 2:47 PM | Regeneron Pharmaceuticals (Subject) STAHL NEIL (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 11:27 AM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023 4:16 PM | Decibel Therapeutics, Inc. (Subject) Regeneron Pharmaceuticals (Filed by)
| Form SC 13D | |
08/10/2023 1:02 PM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 5:56 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 5:48 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 1:14 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023 11:07 AM | Regeneron Pharmaceuticals (Subject) RYAN ARTHUR F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:23 PM | McCourt Marion (Reporting) Regeneron Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023 3:08 PM | MURPHY ANDREW J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:11 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 6:14 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2023 6:37 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2023 6:01 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2023 3:39 PM | LAROSA JOSEPH J (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2023 3:41 PM | Regeneron Pharmaceuticals (Issuer) YANCOPOULOS GEORGE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2023 3:42 PM | Regeneron Pharmaceuticals (Issuer) VAGELOS P ROY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2023 3:43 PM | Bassler Bonnie L (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2023 3:37 PM | Fenimore Christopher R. (Reporting) Regeneron Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |